Thermo Fisher Scientific

Thermo Fisher Scientific

Yahoo Finance • 4 hours ago

Microarray Analysis - Global Strategic Business Report 2026: Secure Share in a $5.1 Billion Market by 2032, Featuring Profiles of Key Players Agilent, Illumina, Roche and Thermo Fisher

Company Logo Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Microarray Analysis - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global microarray analysis market was valued at US$3.3 billion... Full story

Yahoo Finance • 5 hours ago

Thermo Fisher (TMO) Emerges as Top Contributor After 27% Quarterly Gain

BUFFALO Funds, an actively managed mutual fund advised by Kornitzer Capital Management, released its third-quarter 2026 investor letter for "Buffalo Growth Fund". The letter can be downloaded here. The Buffalo Growth Fund advanced 4.57% in... Full story

Yahoo Finance • 6 hours ago

Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share

Company Logo Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Glycomics / Glycobiology - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global glycomics / glycobiology market was valued at US$1.... Full story

Yahoo Finance • 10 hours ago

What JPMorgan Nasdaq Equity Premium Income (JEPQ) Sold: Marriott Leads on Monday

This article first appeared on GuruFocus. JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) kept up its recent pattern of trimming, with 78 positions decreased against only four increased on Monday, Nov. 2. The fund's ETF activity totaled... Full story

Yahoo Finance • yesterday

Cell Harvesting - Global Strategic Business Report: Capitalize on 7.6% CAGR to US$516.3 Million by 2030 as Thermo Fisher Scientific, PerkinElmer, Corning and Sartorius Accelerate Automation

Company Logo Boost ROI with automated cell harvesting, precision microfluidics, scalable biopharma workflows, and opportunities in personalized and regenerative medicine. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Cell Harvesting - Globa... Full story

Yahoo Finance • yesterday

Biobanks - Global Strategic Business Report: Capitalize on a US$51.7 Billion Revenue Surge by 2030 as Thermo Fisher Scientific, Merck KGaA, BioLifeSolutions, and Tecan Reshape the Market

Company Logo Capitalize on precision medicine, genomic research and automated biobanking, with tariff insights guiding sourcing, expansion and revenue opportunities. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biobanks - Global Strategic... Full story

Yahoo Finance • yesterday

Metabolomics - Global Strategic Business Report: Capitalize on an 11.7% CAGR to Secure the $7.1 Billion 2030 Market as Thermo Fisher, Agilent, Bruker, Waters, and Metabolon Reshape Competition

Company Logo Precision medicine, biomarker and drug discovery, multi-omics, AI analytics, and rising pharma investment are accelerating metabolomics adoption. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Metabolomics - Global Strategic Bus... Full story

Yahoo Finance • yesterday

Biopreservation - Global Strategic Business Report: Capitalize on 18.2% CAGR to $10.7 Billion by 2032 as BioLife Solutions, Thermo Fisher Scientific, Qiagen, and Panasonic Reshape the Market

Company Logo Target equipment, cryopreservation media, biobanking and regenerative medicine; leverage GMP compliance, R&D funding and Asia-Pacific expansion. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biopreservation - Global Strategic B... Full story

Yahoo Finance • yesterday

Devyser Diagnostics AB (OSTO:DVYSR) (Q3 2026) Earnings Call Highlights: Strong Margins and ...

This article first appeared on GuruFocus. Release Date: November 03, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Devyser Diagnostics AB (OSTO:DVYSR) reported... Full story

Yahoo Finance • yesterday

Clean Sweep for Seven Companies in Extel’s 2026 U.S. Corporates Survey

Delta, Eli Lilly, JPMorgan Chase, NVIDIA, Quanta Services, Thermo Fisher Scientific and Visa took first place in every category for their sectors. Walmart recorded the 2026 survey's highest weighted score. NEW YORK, November 03, 2026--(BU... Full story

Yahoo Finance • yesterday

3 S&P 500 stocks we find risky

3 S&P 500 stocks we find risky While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.... Full story

Yahoo Finance • 2 days ago

Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

Company Logo R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization. Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Biotechnology Reag... Full story

Yahoo Finance • 5 days ago

How Investors Are Reacting To Thermo Fisher Scientific Stock After Strong Q3 Earnings

Thermo Fisher Scientific reported past third quarter 2026 results with sales of US$12.137b and net income of US$1.721b, with earnings per share from continuing operations modestly higher than a year earlier on both a basic and diluted basi... Full story

Yahoo Finance • 5 days ago

Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN

Company Logo Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Human Papillomavirus (HPV) Genotyping Panels Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global human papillomavirus (HPV) genotyping panels... Full story

Yahoo Finance • 5 days ago

Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche

Company Logo Profiles Roche Diagnostics, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies and Silence Therapeutics, covering their RNAi technology market activities. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Ribonucleic Acid (... Full story

Yahoo Finance • 5 days ago

Global CRISPR Fluorescence Assays Market Report 2026 | Capitalize on 19.5% CAGR to 2030 with Thermo Fisher, Merck, QIAGEN, and Mammoth Biosciences Driving Multiplex Diagnostics

Company Logo Boost ROI via multiplex, AI-enabled and point-of-care assays; expand personalized diagnostics and localize reagent production to reduce tariff exposure. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Clustered Regularly Interspa... Full story

Yahoo Finance • 5 days ago

Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina

Company Logo Players: Thermo Fisher, Labcorp, Quest Diagnostics, Eurofins, Agilent. Profiles cover fetal aneuploidy tests, technologies, applications and end users. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Aneuploidy Confirmation... Full story

Yahoo Finance • 5 days ago

Global Gene Panel Reconciliation Services Market Report 2026 | Capitalize on AI-Driven Genomics as Roche, Thermo Fisher, Illumina and QIAGEN Accelerate a $2.38B Market by 2030

Company Logo Players: Roche, Thermo Fisher, IQVIA, Labcorp, Eurofins. Profiled: gene-panel design, harmonization, interpretation, reporting, technologies, applications and regions. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Gene Panel Re... Full story

Yahoo Finance • 5 days ago

2 cash-producing stocks with promising prospects and 1 we avoid

2 cash-producing stocks with promising prospects and 1 we avoid Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading... Full story

Yahoo Finance • 6 days ago

Global Reverse Transcription Kits Market Report 2026 | Capitalize on 8.4% CAGR as Roche, Thermo Fisher, Merck, QIAGEN and Promega Accelerate Automation and NGS

Company Logo Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Reverse Transcription Kits Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global reverse transcription kits market is experiencing strong growth... Full story